Impact of moderate or severe renal insufficiency on long-term outcomes in patients undergoing drug-eluting stent based coronary intervention

International Journal of Cardiology

Volumn 136, Issue 1, 2009, Pages 72-79

  Zhang, Rui Yan ^a   Zhu, Zheng Bin ^a   Zhang, Qi ^a   Yang, Zhen Kun ^a   Hu, Jian ^a   Lv, An Kang ^a   Zhang, Jian Sheng ^a   Shen, Wei Feng ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Clinical outcome; Drug eluting stent; Percutaneous coronary intervention; Renal insufficiency

Indexed keywords

HEMOGLOBIN;

ADULT; AGED; ANEMIA; ANGIOCARDIOGRAPHY; ARTICLE; BODY WEIGHT; CIGARETTE SMOKING; CONTROLLED STUDY; CORONARY STENT; CREATININE CLEARANCE; DIABETES MELLITUS; DISEASE SEVERITY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; GROUPS BY AGE; HEART DEATH; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVASCULARIZATION; RISK ASSESSMENT; SEX DIFFERENCE;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 67649868298     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.04.028     Document Type: Article

References (40)

1. Ferrer-Hita J.J., Dominguez-Rodriguez A., Garcia-Gonzalez M.J., and Abreu-Gonzalez P. Renal dysfunction is an independent predictor of in-hospital mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty. Int J Cardiol 31 (2007) 243-245
2. Lip G.Y.H., Rathore V.S., Katira R., Singh S.P., and Watson R.D.S. Changes in renal function with percutaneous transluminal coronary angioplasty. Int J Cardiol 70 (1999) 127-131
3. Ferrer-Hita J.J., Dominguez-Rodriguez A., Garcia-Gonzalez M.J., and Abreu-Gonzalez P. Renal dysfunction is an independent predictor of in-hospital mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty. Int J Cardiol 118 (2007) 243-245
4. Schoebel F.C., Gradaus F., Ivens K., et al. Restenosis after elective coronary balloon angioplasty in patients with end-stage renal disease: a case-control study using quantitative coronary angiography. Heart 78 (1997) 337-342
5. Al Suwaidi J., Reddan D.N., Williams K., et al., GUSTO-IIb, GUSTO-III, PURSUIT. Global use of strategies to open occluded coronary arteries. Platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy; PARAGON-A Investigators. Platelet IIb/IIIa antagonism for the reduction of acute coronary syndrome events in a global organization network. Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation 106 (2002) 974-980
6. Daemen J., and Serruys P.W. Drug-eluting stent update 2007: Part II: unsettled issues. Circulation 116 (2007) 961-968
7. Regar E., Serruys P.W., Bode C., et al., RAVEL Study Group. Angiographic findings of the multicenter randomized study with the sirolimus-eluting Bx velocity balloon-expandable stent (RAVEL): sirolimus-eluting stents inhibit restenosis irrespective of the vessel size. Circulation 106 (2002) 1949-1956
8. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41
9. National Kidney Foundation (NKF) Kidney Disease Outcome Quality Initiative (K/DOQI) Advisory Board. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative. Am J Kidney Dis 39 suppl 2 (2002) S1-S246
10. Zhang R.Y., Ni J.W., Zhang J.S., et al. Long term clinical outcomes in patients with moderate renal insufficiency undergoing stent based percutaneous coronary intervention. Chin Med J (Engl) 119 (2006) 1176-1181
11. Cutlip D.E., Windecker S., Mehran R., et al. Clinical end points in coronary stent trials. A case for standardized definitions. Academic research consortium. Circulation 115 (2007) 2344-2351
12. Best P.J., et al., For the PRESTO Investigators. Impact of mild or moderate chronic kidney disease on the frequency of restenosis: results from the PRESTO Trial. J Am Coll Cardiol 44 (2004) 1786-1791
13. Manske C.L., Wang Y., Rector T., Wilson R.F., and White C.W. Coronary revascularisation in insulin-dependent diabetic patients with chronic renal failure. Lancet 340 (1992) 998-1002
14. Best P.J., Lennon R., Ting H.H., et al. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 39 (2002) 1113-1119
15. Cooper W.A., O'Brien S.M., Thourani V.H., et al. Impact of renal dysfunction on outcomes of coronary artery bypass surgery: results from the Society of Thoracic Surgeons National Adult Cardiac Database. Circulation 113 (2006) 1063-1070
16. van de Wal R.M., van Brussel B.L., Voors A.A., et al. Mild preoperative renal dysfunction as a predictor of long-term clinical outcome after coronary bypass surgery. J Thorac Cardiovasc Surg 129 (2005) 330-335
17. Urban P., Gershlick A.H., Guagliumi G., et al., e-Cypher Investigators. Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry. Circulation 113 (2006) 1434-1441
18. Lopez-Minguez J.R., Nogales J.M., Morales A., Alonso R., Gonzalez R., and Merchan A. Clinical and angiographic follow-up in patients with Cypher or Taxus stents in populations with high percentage of trial-excluded lesions. Cardiovasc Revasc Med 6 (2005) 92-98
19. Lemos P.A., Arampatzis C.A., Hoye A., et al. Impact of baseline renal function on mortality after percutaneous coronary intervention with sirolimus-eluting stents or bare metal stents. Am J Cardiol 95 (2005) 167-172
20. Halkin A., Selzer F., Marroquin O., Laskey W., Detre K., and Cohen H. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients. J Invasive Cardiol 18 (2006) 577-583
21. Halkin A., Mehran R., Casey C.W., et al. Impact of moderate renal insufficiency on restenosis and adverse clinical events after paclitaxel-eluting and bare metal stent implantation: results from the TAXUS-IV Trial. Am Heart J 150 (2005) 1163-1170
22. Herzog C.A., Ma J.Z., and Collins A.J. Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes. Circulation 106 (2002) 2207-2211
23. Hall W.D. Abnormalities of kidney function as a cause and a consequence of cardiovascular disease. Am J Med Sci 317 (1999) 176-182
24. Cheung A.K., Sarnak M.J., Yan G., et al. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int 58 (2000) 353-362
25. He J., and Whelton P.K. Elevated systolic blood pressure as a risk factor for cardiovascular and renal disease. J Hypertens 17 (1999) 7-13 Suppl S
26. Keane W.F., and Collins A.J. Influence of co-morbidity on mortality and morbidity in patients treated with hemodialysis. Am J Kidney Dis 24 (1994) 1010-1018
27. Kanani P.M., Sinkey C.A., Browning R.L., Allaman M., Knapp H.R., and Haynes W.G. Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans. Circulation 100 (1999) 1161-1168
28. Herrmann W., Quast S., Ellgass A., et al. An increased serum level of free Apo(a) in renal patients is more striking than that of Lp (a) and is influenced by homocysteine. Nephron 85 (2000) 41-49
29. Romanic A.M., Arleth A.J., Willette R.N., and Ohlstein E.H. Factor XIIIa cross-links lipoprotein (a) with fibrinogen and is present in human atherosclerotic lesions. Circ Res 83 (1998) 264-269
30. Ravani P., Tripepi G., Malberti F., Testa S., Mallamaci F., and Zoccali C. Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: a competing risks modeling approach. J Am Soc Nephrol 16 (2005) 2449-2455
31. Bassand J.P. Impact of anaemia, bleeding, and transfusions in acute coronary syndromes: a shift in the paradigm. Eur Heart J 28 (2007) 1273-1274
32. Kiamk E., Solski J., Janicka L., and Zagojska M. Lipid and lipoprotein ratios as risk factors of atherosclerosis in patients with chronic renal insufficiency. Int Urol Nephrol 31 (1999) 263-267
33. Shoji T., Nishizawa Y., Kawagishi T., et al. Atherogenic lipoprotein changes in the absence of hyperlipidemia in patients with chronic renal failure treated by dialysis. Atherosclerosis 131 (1997) 229-236
34. Schettler V., Wieland E., Methe H., Schuff-Werner P., and Muller G.A. Oxidative stress during dialysis: effect on free radical scavenging enzyme (FRSE) activities and glutathione (GSH) concentration in granulocytes. Nephrol Dial Transplant 13 (1998) 2588-2593
35. Gesquiere L., Loreau N., Minnich A., Davignon J., and Blache D. Oxidative stress leads to cholesterol accumulation in vascular smooth muscle cells. Free Radic Biol Med 27 (1999) 134-145
36. Le Feuvre C., Dambrin G., Helft G., et al. Comparison of clinical outcome following coronary stenting or balloon angioplasty in dialysis versus non-dialysis patients. Am J Cardiol 85 (2000) 1365-1368
37. Conlon P.J., Kovalik E., Schumm D., Minda S., and Schwab S.J. Normalization of hematocrit in hemodialysis patients does not affect silent ischemia. Ren Fail 22 (2000) 205-211
38. Rourke R.A. Role of myocardial revascularization in sudden cardiac death. Circulation 85 Suppl 1 (1992) I112-I117
39. Myerburg R.J., Kessler K.M., and Castellanos A. Sudden cardiac death: epidemiology, transient risk, and intervention assessment. Ann Intern Med 119 (1993) 1187-1197
40. Holzmann M.J., Hammar N., Ahnve S., Nordqvist T., Pehrsson K., and Ivert T. Renal insufficiency and long-term mortality and incidence of myocardial infarction in patients undergoing coronary artery bypass grafting. Eur Heart J 28 (2007) 865-871